Accenture Sees AI Solutions For IDMP Compliance, Trial Efficiency
40% Of Client Sites Studied Recruited Zero Patients
Executive Summary
AI could help companies comply with regulations like GDPR and IDMP, apart from optimizing clinical trial processes, Accenture’s managing director leading R&D analytics in North America says, as he lists cases where the firm drove cost savings.
You may also be interested in...
Doing It The Nike Way – Novartis, AstraZeneca On Making The Metaverse Work
From AstraZeneca’s training program for its representatives to Pfizer’s campaign to drive vaccination in Brazil, the industry is taking a leaf out of Nike’s playbook in adopting the metaverse. Novartis’ executive director and AZ’s director of learning discussed applications and challenges at a recent event.
Global R&D Heads Talk Superbugs, PROTACs And More
A panel of R&D experts from Merck’s EMD Serono, Boehringer Ingelheim, Takeda and Hilleman Labs discuss technologies like PROTACs and multi-specific antibodies, a superbug that could cause more damage than COVID-19 and the need for harmonized regulation that recognizes risk is essential to discovery
EU Decentralized Trials Guide Due Early In 2022
The upcoming EU guideline on decentralized clinical trials is the result of a “learning by doing” exercise and builds on various pilots and initiatives launched by different member states.